Hi Odds
This is the explanation:
https://www.ema.europa.eu/en/about-us/what-we-do/authorisation-medicines#:~:text=mutual%2Drecognition%20procedure%2C%20whereby%20a,in%20several%20EU%20Member%20States.
However, if a drug has been approved by the FDA, based on clinical trial data, I think it is highly likely that the EMA would evaluate the same data to make a decision. ie no need for a separate series of clinical trials. The EMA would make its own decision - but based on the same data.
Cheers
Dave
Hi OddsThis is the...
-
- There are more pages in this discussion • 6,463 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 4.9¢ | 4.8¢ | $328.5K | 6.792M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 45 | 5443565 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 2171910 | 5 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |